Patents by Inventor Adam Libby

Adam Libby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240400542
    Abstract: Sulfonyl-triazole compounds and related sulfonyl-heterocycle compounds are described. The compounds can form covalent adducts with reactive nucleophilic amino acid residues, e.g., reactive tyrosines and reactive lysines, in kinases to form modified kinases and/or alter the biological activity of the kinases. Kinases targetable by the compounds include cyclin-dependent kinase 2 (CDK2), diacylglycerol kinases (DGKs), and phosphofructokinase (PFK). Pharmaceutical compositions including the compounds and methods of inhibiting kinases are also described.
    Type: Application
    Filed: August 19, 2022
    Publication date: December 5, 2024
    Applicant: University of Virginia Patent Foundation
    Inventors: Ku-Lung Hsu, Kun Yuan, Minhaj Shaikh, Xiaoding Jiang, Tao Huang, Adam Libby
  • Publication number: 20220251085
    Abstract: Purine-derived covalent probes (e.g., halo or di-halo-substituted purine based covalent probes) and related ligands are described. The compounds can be used to identify reactive nucleophilic amino acid residues, such as reactive cysteine residues, in proteins and to modify the activity of proteins with reactive nucleophilic amino acid residues (e.g., reactive cysteine residues) via the formation of protein adducts comprising the ligands Modified proteins prepared from the probes and ligands are also described.
    Type: Application
    Filed: July 21, 2020
    Publication date: August 11, 2022
    Applicant: University of Virginia Patent Foundation
    Inventors: Ku-Lung Hsu, Adam Libby, Andy Heindel, Jeffrey W. Brulet, Boobalan Pachaiyappan